• Mashup Score: 0

    Isla Garraway discusses the innovative strides being made in the Veterans Affairs (VA) system towards improving cancer care for veterans, particularly African-American vets. She details the success of initiatives like the partnership with the Prostate Cancer Foundation and the Precision Oncology Program, which facilitate critical genetic testing for veterans with metastatic prostate cancer. A…

    Tweet Tweets with this article
    • Enhancing precision #oncology for #Veterans through @DeptVetAffairs's strategic partnerships. Isla Garraway @UclaUrology joins @SamWashUro to discuss cancer care advancements in the VA system, especially for African-American vets. #WatchNow > https://t.co/IMc0AJ4f0L https://t.co/UDnQfXg35m

  • Mashup Score: 0

    Stephen Williams and Sam Chang discuss the relationship between Agent Orange and bladder cancer. They highlight a retrospective cohort study conducted on over 25 million veterans to determine the association between Agent Orange exposure and bladder cancer incidence. The study controlled for various factors and found a slight increase in bladder cancer risk among veterans exposed to Agent…

    Tweet Tweets with this article
    • #AgentOrange and #BladderCancer: Insights from a study on 25 million #Veterans. @SWilliams_MD @UTMBUrology and @UroCancerMD @VUMCurology highlight a retrospective cohort study looking at Agent Orange exposure and bladder cancer incidence > https://t.co/HvMTv16a4r https://t.co/OmNviys28V

  • Mashup Score: 2

    HONOLULU — Follow-up high-resolution CT scans for veterans with incidental pulmonary nodules, initially assessed for unexplained dyspnea, revealed that nodule stability is common, according to research presented at the CHEST Annual Meeting.“Although our study was focused on understanding the presence and evolution of pulmonary nodules in post-deployment veterans with unexplained

    Tweet Tweets with this article
    • 🗨️At #CHEST2023: "To our surprise, in this highly selective small population [of #veterans], the incidence of pulmonary #nodules was similar to the civilian population,” Richa Nahar, MD, at @Rutgers_NJMS, told Healio. https://t.co/gWhIRRS0zL

  • Mashup Score: 0

    HONOLULU — Follow-up high-resolution CT scans for veterans with incidental pulmonary nodules, initially assessed for unexplained dyspnea, revealed that nodule stability is common, according to research presented at the CHEST Annual Meeting.“Although our study was focused on understanding the presence and evolution of pulmonary nodules in post-deployment veterans with unexplained

    Tweet Tweets with this article
    • Presented at #CHEST2023🌺: Follow-up high-resolution CT scans for #veterans🎖️ with incidental pulmonary #nodules, initially assessed for unexplained #dyspnea, revealed that nodule stability is common. @accpchest https://t.co/gWhIRRS0zL

  • Mashup Score: 6

    PURPOSE Veteran populations have higher lung cancer incidence and worse overall survival compared with non-Veteran populations. Although recent clinical advancements have reduced lung cancer death rates, these advances are not routinely received among Veteran populations because of multilevel factors, including Veterans’ complex comorbidities, limited health literacy, and other economic and social disadvantages. This study aimed to assess Veterans’ perspectives regarding their lung cancer care with a specific focus on identifying modifiable barriers to evidence-based care delivery. METHODS We conducted 1:1 semistructured interviews with 24 Veterans diagnosed with lung cancer at the Veterans Affairs Palo Alto Health Care System. All interviews were recorded, transcribed, and analyzed using the constant comparative method of qualitative analysis. RESULTS Four themes emerged. These included (1) social and economic disadvantages can prevent routine delivery of evidence-based cancer care; (

    Tweet Tweets with this article
    • ⁦important work w ⁦@_Chris__Lopez_⁩ ⁦@DasMillie11⁩ ⁦@VAPaloAlto⁩ sheds light on important #Barriers, #Facilitators to #CancerCare Among #Veterans w #LungCancer. Interventions underway from this work! #lcsm ⁦@StanfordDeptMed⁩ https://t.co/PNBdFSprnK